DOGS

• Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders
• Reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery

CATS

• Reduction of pain after surgery
• Management of febrile conditions in combination with approriate antibiotics

DOGS

MUSCULOSKELETAL DISORDERS: Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg bodyweight (i.e., 0.4 mL/10 kg bodyweight). Meloxiway 5mg/mL Injection should be used for continuation of treatment at a dosage of 0.1 mg meloxicam/kg bodyweight, 24 hours after administration of the injection.

REDUCTION OF POST-OPERATIVE PAIN: Single intravenous or subcutaneous injection at a dosage of 0.2 mg meloxicam/kg bodyweight (i.e., 0.4 mL/10 kg bodyweight) before surgery, for example at the time of induction of anaesthesia.

CATS

REDUCTION OF POST-OPERATIVE PAIN: Single subcutaneous injection at a dosage of 0.3 mg meloxicam/kg bodyweight (i.e., 0.06 mL/kg bodyweight) directly prior to induction of anaesthesia.

MANAGEMENT OF FEBRILE CONDITIONS: Single subcutaneous injection at a dosage of 0.3 mg meloxicam/kg bodyweight (i.e., 0.06 mL/kg bodyweight).